Biomarkers and Response to Bevacizumab—Response
نویسندگان
چکیده
منابع مشابه
Use of Apoptotic Biomarkers to Predict Response to Radiotherapy in Breast Cancer Patients
Introduction: To enhance radiation therapy efficiency it is crucial to implement an individual-based treatment. The aim of present study was to identify the mechanism of intrinsic apoptosis pathway on radiosensitivity and normal tissue complications caused by the radiotherapy. Materials and Methods: radiation-induced apoptosis in periphera...
متن کاملBiomarkers to Predict Antidepressant Response
During the past several years, we have achieved a deeper understanding of the etiology/pathophysiology of major depressive disorder (MDD). However, this improved understanding has not translated to improved treatment outcome. Treatment often results in symptomatic improvement, but not full recovery. Clinical approaches are largely trial-and-error, and when the first treatment does not result in...
متن کاملBiomarkers and response to bevacizumab--letter.
We read with interest the proteomic study by Collinson and colleagues (1), proposing a biomarker signature with promising ability in predicting benefit from the addition of bevacizumab to standard chemotherapy in epithelial ovarian cancer (EOC). The identification of predictors of benefit from bevacizumab is one of the most pressing priority in medical oncology, as indications for its use have ...
متن کاملresponse articles: micro and macro analysis
the present study reports an analysis of response articles in four different disciplines in the social sciences, i.e., linguistics, english for specific purposes (esp), accounting, and psychology. the study has three phases: micro analysis, macro analysis, and e-mail interview. the results of the micro analysis indicate that a three-level linguistic pattern is used by the writers in order to cr...
15 صفحه اولذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Clinical Cancer Research
سال: 2014
ISSN: 1078-0432,1557-3265
DOI: 10.1158/1078-0432.ccr-13-3269